Meditope Biosciences, Inc. Email Format
Biotechnology ResearchCalifornia, United States2-10 Employees
Meditope Biosciences, Inc. is a biotechnology research company based in Pasadena, California, with a small team of 2 to 10 employees. It develops and applies a proprietary antibody platform called SnAP, which enables site-specific, modular attachment and removal of diverse payloads—including toxins, proteins, radiolabels, and other antibodies—to achieve controlled, predictable conjugation. The company is pursuing a preclinical pipeline of cancer therapeutics, including two immuno-oncology products aimed at prostate and bladder cancers. Meditope has a history of collaborations and governance activity, including a 2019 collaboration with Sanofi to develop a bioconjugation platform, and announced leadership appointments and a Series A financing in the 2010s. More information is available on its website at https://meditope.com.